How much funding has mFluiDX raised?

mFluiDX has raised $2.0M in total funding, most recently a Grant round.

Where is mFluiDX headquartered?

mFluiDX is headquartered in Oakland, California, United States.

What industry is mFluiDX in?

mFluiDX operates in Biotech, Healthcare.

mFluiDX

Q: Who are mFluiDX's investors?

mFluiDX's investors include National Institutes of Health, IndieBio.

Enabling molecular detection anywhere

Oakland, United States · Founded 2016 · $2.0M raised

Biotech

Healthcare

Headquarters: Oakland, California
Employees: 1–10
Founded: 2016
Business Model: B2B

Website: mfluidx.com
Total Funding: $2.0M
Last Round: $1.8M GrantJan 2019
Rounds: 2

About

mFluiDx is a UC Berkeley spinout developing the SIMPLE CHIP, a low-cost point-of-care molecular diagnostic device that achieves PCR-equivalent sensitivity at the price of rapid antigen tests. The platform uses isothermal amplification and microfluidic technology to simultaneously detect multiple bacterial and viral pathogens from a single cartridge in 7–15 minutes, with fully automated sample-to-answer processing. Founded by Charlie Yeh (UCSF/UC Berkeley Joint PhD), the company is funded by NIH SBIR Phase I and Phase II grants, the Gates Foundation, and received seed funding through the IndieBio accelerator. It was a TechCrunch Battlefield finalist.

Summary

mFluiDX is a Biotech company based in Oakland, United States, founded in 2016. It has raised $2.0M in total across 2 rounds, most recently a $1.8M Grant round in Jan 2019. Investors include National Institutes of Health and IndieBio.

LinkedIn X (Twitter)